CEP33779.COM
Updated 41 days ago
The recent controversy regarding whether COX-2 drugs increase the risk of coronary disease via prothrombotic effects occurred following the completion of the audit, therefore this presssing issue had not been contained in the audit form or analysis of risk factors [27, 28]